SalaryGuide
AboutPricingFor Employers

Marketing jobs

9 marketing jobs

SUN PHARMA logo
6 weeks ago

Associate Director, Marketing - Biologics

SUN PHARMA

Princeton, NJ (Hybrid)Full time$165K/yr – $201K/yr
SUN PHARMA logo
7 weeks ago

Associate Director, Marketing - Medical Dermatology

SUN PHARMA

Princeton, NJ (Hybrid)Full time$165K/yr – $201K/yr
SUN PHARMA logo
2 months ago

Associate, Product Marketing (LTC)

SUN PHARMA

Princeton, NJ (On-site)Full time$85K/yr – $104K/yr
SUN PHARMA logo
2 months ago

Senior Marketing Analyst

SUN PHARMA

Hawthorne, NY (On-site)Full time$110K/yr – $123K/yr
SUN PHARMA logo
3 months ago

Associate Director, Marketing - Ophthalmics

SUN PHARMA

Princeton, NJ (On-site)Full time$165K/yr – $201K/yr
SUN PHARMA logo
3 months ago

Associate Director, CRM-IT

SUN PHARMA

Princeton, NJ (On-site)Full time$157K/yr – $192K/yr
SUN PHARMA logo
3 months ago

Director, Marketing

SUN PHARMA

Princeton, NJ (Hybrid)Full time$171K/yr – $209K/yr
SUN PHARMA logo
4 months ago

Marketing Director, Ophthalmics, Princeton, NJ - Hybrid

SUN PHARMA

Princeton, NJ (Hybrid)Full time$171K/yr – $209K/yr
SUN PHARMA logo
5 months ago

Associate, Brand Marketing, Hawthorne, NY - Hybrid

SUN PHARMA

Hawthorne, NY (Hybrid)Full time$89K/yr – $108K/yr

All marketing roles in the US

Get alerts for this search

All marketing roles in the US

Get alerts for this search

9 jobs
SUN PHARMA logo

Associate Director, Marketing - Biologics

SUN PHARMA

Princeton, NJ (Hybrid)

$165K/yr - $201K/yrIn-houseFull-timeSenior level7+ years exp.
6 weeks ago
SUN PHARMA logo

Associate Director, Marketing - Medical Dermatology

SUN PHARMA

Princeton, NJ (Hybrid)

$165K/yr - $201K/yrIn-houseFull-timeSenior level7+ years exp.
7 weeks ago
SUN PHARMA logo

Associate, Product Marketing (LTC)

SUN PHARMA

Princeton, NJ (On-site)

$85K/yr - $104K/yrIn-houseFull-timeEntry level
2 months ago
SUN PHARMA logo

Senior Marketing Analyst

SUN PHARMA

Hawthorne, NY (On-site)

$110K/yr - $123K/yrIn-houseFull-timeSenior level5+ years exp.
2 months ago
SUN PHARMA logo

Associate Director, Marketing - Ophthalmics

SUN PHARMA

Princeton, NJ (On-site)

$165K/yr - $201K/yrIn-houseFull-timeSenior level5+ years exp.
3 months ago
SUN PHARMA logo

Associate Director, CRM-IT

SUN PHARMA

Princeton, NJ (On-site)

$157K/yr - $192K/yrIn-houseFull-timeSenior level8+ years exp.
3 months ago
SUN PHARMA logo

Director, Marketing

SUN PHARMA

Princeton, NJ (Hybrid)

$171K/yr - $209K/yrIn-houseFull-timeDirector/executive5+ years exp.
3 months ago
SUN PHARMA logo

Marketing Director, Ophthalmics, Princeton, NJ - Hybrid

SUN PHARMA

Princeton, NJ (Hybrid)

$171K/yr - $209K/yrIn-houseFull-timeDirector/executive5+ years exp.
4 months ago
SUN PHARMA logo

Associate, Brand Marketing, Hawthorne, NY - Hybrid

SUN PHARMA

Hawthorne, NY (Hybrid)

$89K/yr - $108K/yrIn-houseFull-timeMid level3+ years exp.
5 months ago
SUN PHARMA logo
SUN PHARMA

Associate Director, Marketing - Biologics

Princeton, NJ (Hybrid)

$165K/yr – $201K/yrSenior Level7+ years expFull time

Posted 6 weeks ago

Top 1% of applicants do these two things.

The other 99% submit and hope. You're about to do something different.

Job Summary

Own strategic brand direction and drive launches and market expansion across dermatology and rheumatology with cross functional execution.

  • Brand Strategy & Leadership: co-own long range brand strategy, align with priorities, and lead annual plans with accountable performance across indications.
  • Launch Strategy & Market Expansion: own end-to-end PsA launch and push market expansion with clear value propositions in competitive biologics markets.
  • Cross-Functional Collaboration: align Sales, Medical Affairs, Market Access, Analytics and Regulatory to turn strategy into measurable results.

Job Description

Own strategic brand direction and drive launches and market expansion across dermatology and rheumatology with cross functional execution.

  • Strategic Leadership & Brand Ownership: co-own long range brand strategy, align with priorities, and lead annual plans with accountable performance across indications.
  • Launch Excellence & Market Expansion: own end-to-end Psoriatic Arthritis launch and drive market expansion with clear value propositions in competitive biologics markets.
  • Customer & Market Strategy: engage HCPs, patients and stakeholders with differentiated messaging and a proactive payer/access stance.
  • Lifecycle Management & Innovation: steer lifecycle strategy, portfolio optimization, and omni channel marketing to improve ROI and reach.
  • Cross-Functional Leadership: act as central integrator across Sales, Medical Affairs, Market Access, Analytics, Finance and Regulatory to translate strategy into results.
SUN PHARMA logo

SUN PHARMA

3.6 Glassdoor

Sun Pharma is the world's fourth-largest speciality generic pharmaceutical company and No. 1 in India. We provide high-quality, affordable medicines trusted by customers and patients in over 100 countries. Sun Pharma's global presence is supported by more than 40 manufacturing facilities spread across 5 continents, R&D centres across the globe, and a multicultural workforce comprising over 50 nationalities. Sun Pharma fosters excellence through innovation supported by strong R&D capabilities comprising around 3,000 scientists and R&D investments of over 6-8% of annual revenues.At Sun, our people are our greatest asset. Ours has never been a story of individual brilliance but of cultivating a culture of realising collective potential. In our journey, everyone is enabled to take charge in an environment that offers limitless growth opportunities. We are with you every step of the way, so you can shine for years to come.With the launch of our Employee Value Proposition (EVP), we define our promise to ‘Create Your Own Sunshine'—driven by the three pillars of Better Every Day, Take Charge, and Thrive Together. These pillars drive progress at Sun so that people can achieve what they would have thought impossible. Learn more about our EVP here: https://sunpharma.com/careers/

Founded in 1983
Mumbai, Maharashtra, IND
44K employees (1,437 in marketing)
www.sunpharma.com
69% recommend to a friend
84% CEO approval

Traffic Signals

Monthly Visitors
197.8K
Traffic Source Mix
Search
48.4%
Direct
40.7%
Referral
6.8%
Social
3.2%
Paid
0.4%

Headcount Trend

Current headcount: ~43.9K

Marketing Team

Marketing Team Size
1,304 (3% of company)
Marketing Roles Posted (Last 30 Days)
1

Recent News

NCLT Approves Sun Pharma's Merger with Subsidiaries, Enhancing Corporate Structure
Oct 8, 2025 • scanx.trade
Bombay HC Grants Relief to Sun Pharma in Trademark Battle Over Lupride
Oct 2, 2025 • Medical Dialogues
Sensex opens nearly 100 points higher, Nifty above 24,500; Sun Pharma up 2%
Oct 1, 2025 • India Today
Sun Pharma exposed to some headline risk amid US tariff move, but with limited earnings impact
Sep 29, 2025 • Medical Dialogues
US Tariffs: Only Sun Pharma exposed to some headline risk, but with limited earnings impact
Sep 28, 2025 • The Economic Times
US Tariffs. Only Sun Pharma exposed to some headline risk, but with limited earnings impact
Sep 28, 2025 • Hindu Business Line
Sun Pharma faces US tariff uncertainty; analysts see limited earnings risk
Sep 27, 2025 • The New Indian Express
Sun Pharma may face tariff turbulence in US but HSBC sees limited earnings risk
Sep 27, 2025 • Moneycontrol
Donald Trump drops 100% tariff bomb on branded drugs as India’s generics industry watches nervously
Sep 27, 2025 • Calcutta Telegraph
Sun Pharma shares fall to 52-week low in response to 100% US tariffs on branded, patented drugs
Sep 26, 2025 • CNBC TV18
Sun Pharma Leads Pharma Stocks Decline After Trump Hikes Tariff To 100%
Sep 26, 2025 • NDTV Profit
Sun Pharma Share Price: Stock drops over 4% post Trump's tariffs on branded drugs, Nifty pharma falls over 2%
Sep 26, 2025 • India TV News
Asian markets drop as US data, new tariff threats dent sentiment
Sep 26, 2025 • Channel NewsAsia
Pharma stocks dive on Trump tariff; Wockhardt tumbles over 9 pc
Sep 26, 2025 • Livemint.com
Indian pharma stocks fall after Trump's new drug tariffs
Sep 26, 2025 • Reuters
Sun Pharma, Lupin, other pharma stocks in focus after Donald Trump announces 100% tariffs on patented drugs
Sep 26, 2025 • Livemint.com
Indian pharma stocks fall after Trumps new drug tariffs; mostly sentimental, say analysts
Sep 26, 2025 • Livemint.com
Nifty Pharma down 2% after U.S. announces tariff on pharma
Sep 26, 2025 • The Hindu
Nifty Prediction Today – September 26, 2025: Nifty futures: Momentum favour bears
Sep 26, 2025 • Hindu Business Line
Sensex, Nifty fall almost 1% each on concerns over Trump’s pharma tariffs
Sep 26, 2025 • Indian Express
Sun Pharmaceutical: Domestic, innovation push eyed; Nuvama maintains 'Hold'
Sep 25, 2025 • Business Standard
Sun Pharma share price drops 5% after Donald Trump slaps 100% tariff on branded pharma | Business News
Sep 25, 2025 • Hindustan Times
Millionaires of Maharashtra – Top 10 richest residents with net worth above Rs 2 lakh cr
Sep 21, 2025 • Financial Express
Sun Pharma has shuffled its top deck. The bet is on.
Sep 20, 2025 • Livemint.com
Sun Pharma shares up by more than 1% today
Sep 18, 2025 • HDFC Sky
Sun Pharma added to Citi's pan-Asia focus list with 35% upside
Sep 18, 2025 • CNBC TV18
Focusing on specific needs key differentiator for Sun Pharma: Dilip Shanghvi
Sep 18, 2025 • ETPharma.com
Adaptability key for success in uncertain times: Sun Pharma's Dilip Shanghvi
Sep 18, 2025 • IndiaTimes
Will legal troubles in the US weigh on India’s obesity drug boom?
Sep 17, 2025 • Livemint.com
AbbVie settles with generic Rinvoq hopefuls, shielding the immunology med's US stronghold until 2037
Sep 11, 2025 • FiercePharma
Encephalopathy Market Worth $209 Million in 2025 Led by Salix Pharma, Abbott Labs, and Fresenius Kabi: Analysis of Key Trends & Strategies
Sep 11, 2025 • Research and Markets
Sun Pharma Shares Slump as USFDA Indicates OAI Status
Sep 10, 2025 • Equitypandit
Sun Pharma Halol plant under Import alert
Sep 10, 2025 • ETPharma.com
India's stock benchmarks set to open higher on US trade talk hopes, rate cut bets
Sep 10, 2025 • Reuters
Sun Pharma’s Halol plant under US FDA import alert, shipments halted
Sep 9, 2025 • CNBC TV18
Sun Pharma's Halol plant gets OAI classification from US FDA inspection
Sep 9, 2025 • Business Standard
FDA Prohibits Sun Pharma Halol Plant from Exporting Drugs to US
Sep 9, 2025 • Pharmaceutical Executive
Fda classifies Sun Pharma Halol facility as 'official action indicated'
Sep 9, 2025 • MarketScreener
Now Sun Pharma, Lupin work on anti-obesity pill to cut costs, address jab aversion | Company Business News
Sep 8, 2025 • livemint.com
Sun Pharma Halts Production of Vecuronium Bromide Injection
Sep 8, 2025 • scanx.trade
Azerbaijan and Hungary sign three deals during Budapest meeting
Sep 4, 2025 • Report.az
Acute Respiratory Distress Syndrome Market Forecast and Company Analysis Report 2025-2033 Featuring Ajanta, Akorn, Alembic, Cipla, Indoco Remedies, J&J, Novartis, Ocular Therapeutix, Sun, Teva
Sep 4, 2025 • Research and Markets
Sun Pharma Gets CDSCO Panel Nod to Manufacture, Market Enzalutamide for Prostate Cancer
Sep 3, 2025 • Medical Dialogues
Sun Pharma stock slips 2% in firm market, nears 52-week low; here's why
Sep 1, 2025 • Business Standard
Sun Pharmaceutical Industries Executes Rs. 980 Crore Block Trade on NSE
Sep 1, 2025 • scanx.trade
Does a common heart attack pill help everyone? Studies disagree
Aug 30, 2025 • Investing.com
Top pharma, FMCG firms line up to buy Wellbeing Nutrition at likely ₹1,500 cr valuation
Aug 29, 2025 • Livemint.com
Seminar: IP That Matters - Behind Orexo’s Milestone Patent Win at the US Court
Aug 29, 2025 • News Powered by Cision
Sun Pharma slips 5% in 2 days, nears 52-wk low; why drug stock trades weak?
Aug 28, 2025 • Business Standard
Sun Pharma shares downgraded by BofA on risks to consensus earnings, premium valuations
Aug 26, 2025 • CNBC TV18
Sun Pharma Wins CDSCO Panel Approval for Phase III Vitiligo Trial of Ruxolitinib Cream
Aug 26, 2025 • Medical Dialogues
Sun, Lupin, Dr Reddy's drop up to 4%; why are pharma stocks falling today?
Aug 26, 2025 • Business Standard India
Sensex, Nifty fall 1% ahead of US tariff implementation
Aug 26, 2025 • Indian Express
Global Suppositories Market to Surpass USD 2.05 Billion by 2030 | MarketsandMarkets™
Aug 25, 2025 • MarketsandMarkets Research Pvt. Ltd.
Gujarat Biotechnology University advisory council head re-appointed
Aug 21, 2025 • Indian Express
Anti-Tumor Drugs Market - Opportunities, Share, Growth and Competitive Analysis and Forecast 2029
Aug 20, 2025 • EIN Presswire
Common Cold Market to Reach $34.3 Billion by 2029 with 6.2% CAGR
Aug 20, 2025 • EIN Presswire
Sun Pharma, Alembic Pharma and 1 other recall products in US
Aug 19, 2025 • Medical Dialogues
Tech Query: Reliance Industries, Hindustan Copper, Federal Bank, Sun Pharmaceutical Industries; what is the outlook & where are these stocks headed?
Aug 16, 2025 • Hindu Business Line
Saudi Arabia OTC Artificial Tears Market Report 2025-2033 | Vision 2030 Boosts Retail and Online Channels, Non-Prescription Eye Care Boom Fuels Expansion - ResearchAndMarkets.com
Aug 15, 2025 • Business Wire
Steroid Induced Glaucoma Market Set to Surge Global Value to Reach USD 2.1 Billion by 2035
Aug 14, 2025 • EIN Presswire
Saudi Arabia Generic Drugs Market Outlook Report 2025-2033 | Government Cost-Cutting, Local Manufacturing, and Public Awareness Fuel Rapid Growth
Aug 14, 2025 • Research and Markets
Mixed Q1 results for top drug firms amid price erosion, tariff threat
Aug 13, 2025 • Business Standard India
Sun Pharma Adv Consolidated June 2025 Net Sales at Rs 9.64 crore, down 42.65% Y-o-Y
Aug 12, 2025 • Moneycontrol
Vistogard Market set to hit $3.2 billion by 2035
Aug 12, 2025 • PRLog
Vitiligo Treatment Strategic Market Research Report 2025-2030 | Increased Psychological and Social Impact of Vitiligo Drives Demand for More Effective Therapies
Aug 12, 2025 • Research and Markets
Triamterene Capsules Market set to hit $1437.5 million by 2035
Aug 12, 2025 • PRLog
Indian generics wave next year set to sink obesity drug price
Aug 6, 2025 • IndiaTimes
Allergic Conjunctivitis Market to Hit USD 4.02 Billion by 2032 | Rising Prevalence of Allergies Drives Steady 4.31% CAGR Growth - SNS Insider
Aug 6, 2025 • SNS Insider pvt ltd
Buy Sun Pharma; target of Rs 1960: Motilal Oswal
Aug 4, 2025 • Moneycontrol
Transcript : Sun Pharmaceutical Industries Limited, Q1 2026 Earnings Call, Jul 31, 2025
Aug 2, 2025 • MarketScreener
Sun Pharma shares fall 5.7% post Q1 results: What should investors do now?
Aug 1, 2025 • livemint.com
Sun Pharma shares tumble 4% post-Q1 results; should you buy, sell or hold?
Aug 1, 2025 • Moneycontrol
Sun Pharma net profit drops 20% to Rs 2,279 crore in Q1
Aug 1, 2025 • Medical Dialogues
Suppositories Market Worth $2.05 billion by 2030 with 4.7% CAGR | MarketsandMarkets™
Aug 1, 2025 • PR Newswire UK
Sun Pharmaceutical says it won't expand US manufacturing base amid tariff concerns
Jul 31, 2025 • The Economic Times
Sun Pharma Standalone June 2025 Net Sales at Rs 5,601.96 crore, up 24.54% Y-o-Y
Jul 31, 2025 • Moneycontrol
India's Sun Pharma reports higher adjusted quarterly profit on strong domestic demand
Jul 31, 2025 • Reuters
Sun Pharma Q1 Results: Net profit declines 20% to ₹2,279 crore; revenue up 9%
Jul 31, 2025 • livemint.com
Sun Pharma Q1 Results: Cons profit falls 20% YoY to Rs 2,278 crore, but revenue rises 10%
Jul 31, 2025 • IndiaTimes
Over the Counter (OTC) Drugs Market Forecast Report 2020-2030: Rising Demand for Self-Care Fuels OTC Drugs Market Growth, Projected to Reach USD 15.48 Billion by 2030
Jul 31, 2025 • Research and Markets
Asthma Treatment Market to Hit USD 36.36 Billion by 2032, Driven by Biologic Adoption and Technological Advancements in Inhalers | SNS Insider
Jul 31, 2025 • SNS Insider pvt ltd
Sun Pharmaceutical Industries Limited Reports Earnings Results for the First Quarter Ended June 30, 2025
Jul 31, 2025 • MarketScreener
Here's why Apollo Hospitals & 2 other stocks are on analyst radar today
Jul 31, 2025 • Business Standard India
Sun Pharma Q1 results: PAT dips 20% to ₹2,279 crore; revenue rises 8.6%
Jul 31, 2025 • Business Standard India
Pharmazz Inc. Announces Enrollment of First Patient in Phase 3 Clinical Trial of Sovateltide for Treating Patients with Cerebral Ischemic Stroke
Jul 29, 2025 • Pharmazz, Inc.
Sun Pharma, Lupin, Dr Reddy's recall products in US market due to manufacturing issues
Jul 27, 2025 • The Economic Times
Sun Pharma, Lupin, Dr Reddy's recall products in US due to mfg issues
Jul 27, 2025 • Business Standard India
Buy or sell: Sumeet Bagadia recommends three stocks to buy on Monday — 28 July 2025
Jul 26, 2025 • Livemint.com
Sun Pharma resolves US antitrust case with $200 mn agreement
Jul 25, 2025 • Business Standard
Sun Pharma Shares Decline On $200 Million US Antitrust Litigation Payout
Jul 25, 2025 • NDTV Profit
Sun Pharma Agrees To Rs 1,654 Cr Settlement In U.S. Pricing Row
Jul 25, 2025 • Medical Dialogues
Stocks to Watch today, July 25: Wipro, IEX, REC, Adani Enterprises, NTPC
Jul 25, 2025 • Business Standard India
Postherpetic Neuralgia PHN Market To Reach $0.99 Billion By 2029 With A Growth Rate Of 6.6%
Jul 24, 2025 • EIN Presswire
Pars Planitis Treatment Market Forecast To 2034 – For Business Leaders, Analysts, And Strategic Teams
Jul 24, 2025 • EIN Presswire
Wilson's Disease Drugs Global Market Expected To Reach $0.85 Billion By 2029
Jul 24, 2025 • EIN Presswire
Tinnitus Market Analysis and Forecast Report 2025-2035 | Pharma Giants Drive Treatment Advances with Off-Label CNS Drugs Amid Intensifying Market Competition
Jul 24, 2025 • Research and Markets
Global Acetaminophen-Opioid Combination Market To Reach $3.88 Billion By 2029 With A Growth Rate Of 5.1%
Jul 24, 2025 • EIN Presswire
Pneumoconiosis Market Analysis 2025 – Insights For Long-Term Investment & Planning
Jul 24, 2025 • EIN Presswire
GLP-1 Receptor Agonist Market Size to Hit USD 193.56 Billion by 2032 - SNS Insider
Jul 23, 2025 • SNS Insider pvt ltd